CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
- Amgen presented at the 46th Annual Goldman Sachs Global Healthcare Conference on June 5, 2025, in Thousand Oaks, California.
- The event followed Amgen's ongoing efforts to advance a broad pipeline of medicines addressing cancer, heart disease, and other conditions.
- Executives Peter Griffith and Jay Bradner delivered the presentation at 9:20 a.m., which was webcast live to media, investors, and the public.
- Amgen, traded on NASDAQ under the ticker AMGN and included in the Dow Jones Industrial Average, received recognition in 2024 from Fast Company for its outstanding innovation.
- The webcast was archived and replayed for 90 days, supporting Amgen's commitment to transparency and stakeholder engagement.
4 Articles
4 Articles


TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the Goldman Sachs 46th Annual Global Healthcare Conference, being held in…
AMGEN TO PRESENT AT GOLDMAN SACHS 46TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
THOUSAND OAKS, Calif., June 5, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the Goldman Sachs 46th Annual Global Healthcare Conference at 9:20 a.m. PT on Tuesday, June 10, 2025. Peter Griffith, executive vice president and chief financial officer…
CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
IRVINE, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced that Arthur Kuan, Chairman &…
Coverage Details
Bias Distribution
- 50% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage